| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 47,679 | 42,960 | 41,811 | 39,974 | | Cost of Revenue | 34,392 | 42,990 | 30,614 | 30,303 | | | Gross Profit | 13,287 | (30) | 11,197 | 9,671 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,681 | 17,485 | 7,679 | 6,489 | | Non Recurring | 540 | 45,455 | 497 | 603 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,066 | (62,970) | 3,021 | 2,579 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (31) | (31) | 215 | (12) | | Earnings Before Interest And Taxes | 5,035 | (63,001) | 3,236 | 2,567 | | Interest Expense | 165 | 447 | 246 | 476 | | Income Before Tax | 4,870 | (63,448) | 2,990 | 2,091 | | Income Tax Expense | 1,319 | (19,035) | 567 | (62) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,551 | (44,413) | 2,423 | 2,153 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,551 | (44,413) | 2,423 | 2,153 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,551 | ($44,413) | $2,423 | $2,153 |
|
1.52% Nasdaq 
Income Statement
